In a first-of-its-kind study, PNNL scientists are learning about how e-cigarettes can lead to changes in proteins at the molecular level that could contribute to disease or other health problems.
PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.
A special issue of the Marine Technology Society Journal, titled “Utilizing Offshore Resources for Renewable Energy Development,” focuses on research and development efforts including those at Pacific Northwest National Laboratory (PNNL).
Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.
In a new video series, PNNL is highlighting six scientific and technical experts in the national security domain throughout the fall. Each was promoted to scientist and engineer level 5 earlier this year.
PNNL researchers developed two web-based tools to assess and mitigate cyberthreats to utilities—inside and outside their firewalls. Both are low cost and can be used by control room operators who are not cybersecurity experts.
The Facility Cybersecurity toolkit, developed by PNNL, is designed for federal facilities to help implement the presidential executive order on cybersecurity, but it is also available for commercial facilities without charge.
PNNL researchers established an Internet of Things Common Operating Environment (IoTCOE) laboratory to explore the risks associated with IoT connectivity to the internet, the energy grid and other critical infrastructures.
A new agreement between Pacific Northwest National Laboratory and The University of Texas at El Paso will create research and internship opportunities.
The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.
Biomedical scientist Brian Thrall co-edited the issue published in the journal NanoImpact. Three of the articles in the issue include multiple PNNL authors.